ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,696,001 | -8.5% | 150,195 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $2,946,068 | +8.5% | 145,055 | -2.5% | 0.00% | 0.0% |
| Q1 2023 | $2,714,841 | -12.8% | 148,840 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $3,113,890 | -19.9% | 150,575 | +1.4% | 0.00% | -50.0% |
| Q3 2022 | $3,886,000 | +11.8% | 148,551 | +8.3% | 0.00% | +100.0% |
| Q2 2022 | $3,477,000 | +196.9% | 137,216 | +269.8% | 0.00% | – |
| Q1 2022 | $1,171,000 | +62.0% | 37,109 | +107.5% | 0.00% | – |
| Q4 2021 | $723,000 | +13.0% | 17,882 | -2.6% | 0.00% | – |
| Q3 2021 | $640,000 | +127.8% | 18,364 | +78.8% | 0.00% | – |
| Q2 2021 | $281,000 | -13.0% | 10,269 | -10.8% | 0.00% | – |
| Q1 2021 | $323,000 | +12.5% | 11,506 | +4.0% | 0.00% | – |
| Q4 2020 | $287,000 | +50.3% | 11,061 | -0.7% | 0.00% | – |
| Q3 2020 | $191,000 | -32.7% | 11,141 | -2.8% | 0.00% | – |
| Q2 2020 | $284,000 | +311.6% | 11,461 | +129.9% | 0.00% | – |
| Q1 2020 | $69,000 | +1.5% | 4,985 | -25.3% | 0.00% | – |
| Q4 2019 | $68,000 | +11.5% | 6,670 | 0.0% | 0.00% | – |
| Q3 2019 | $61,000 | +29.8% | 6,670 | +14.6% | 0.00% | – |
| Q2 2019 | $47,000 | -35.6% | 5,818 | 0.0% | 0.00% | – |
| Q1 2019 | $73,000 | +17.7% | 5,818 | 0.0% | 0.00% | – |
| Q4 2018 | $62,000 | +210.0% | 5,818 | +311.5% | 0.00% | – |
| Q3 2018 | $20,000 | +122.2% | 1,414 | +85.3% | 0.00% | – |
| Q2 2018 | $9,000 | – | 763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |